Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TIAN.SI)
25 Jul 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|53||2012||Chairman of the Board, General Manager|
|44||2012||Chief Accounting Officer, Deputy General Manager, Director|
|52||2012||Deputy General Manager, Chief Engineer, Director|
|49||2008||Deputy General Manager|
- BRIEF-Tianjin Zhongxin Pharmaceutical Group to pay A shares annual div for FY 2016 on July 14
- BRIEF-Tianjin Zhongxin Pharmaceutical group entered into a share transfer agreement with Jiaxing Yun Shi Tai Yu Investment Partnership
- BRIEF-Tianjin Zhongxin Pharmaceutical to pay annual cash div as 1.5 yuan per 10 shares for FY 2016
- BRIEF-Tianjin Zhongxin Pharmaceutical to use up to 6.5 mln yuan to buy 20 pct stake in Chinese medicine unit
- BRIEF-Tianjin Zhongxin Pharma's 2016 net profit down 6.4 pct y/y